Bovine Heart Tissue Extract

Bovine heart tissue extract is a preparation derived from cardiac muscle of cattle, containing proteins, peptides, coenzymes such as CoQ10, and mitochondrial components native to heart tissue. It is currently used primarily as a nutrient base in microbial culture media rather than as a validated human therapeutic supplement.

Origin & History

Bovine heart tissue extract is derived from the heart muscle of cattle (Bos taurus), processed into powder form through acid solubilization, homogenization, and centrifugation. The extract contains myofibrillar proteins, water-soluble proteins, and lipid-soluble proteins, with commercial products standardized to ≥10% total nitrogen and ≥3% amino-nitrogen.

Historical & Cultural Context

No historical or traditional medicinal uses are documented in any traditional medicine systems. All references are confined to modern extraction methods for research and microbial media applications.

Health Benefits

• No documented health benefits - no human clinical trials identified in available research
• Currently used only in microbial culture media and research applications
• No evidence for therapeutic efficacy in humans
• No biomedical applications substantiated in the literature
• Lack of clinical data prevents health benefit claims

How It Works

Bovine heart tissue extract contains mitochondria-dense cardiac muscle proteins, native coenzyme Q10 (ubiquinone), cytochrome c, and various peptide fragments that theoretically interact with cellular bioenergetic pathways. The CoQ10 component may support mitochondrial electron transport chain function at complexes I and III, while cardiac-specific peptides could interact with adrenergic receptor signaling, though these mechanisms have not been demonstrated in controlled human studies. Enzymatic cofactors such as NAD+ precursors present in heart tissue may also theoretically support cellular redox reactions, but no in vivo pathway confirmation exists for the whole extract.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses were identified in the available sources for bovine heart tissue extract as a biomedical supplement. The research focuses exclusively on extraction protocols and protein characterization for laboratory use, with no PMIDs for clinical studies found.

Clinical Summary

No published human clinical trials have evaluated bovine heart tissue extract as a dietary supplement for any health outcome. The ingredient appears in scientific literature almost exclusively in the context of brain-heart infusion (BHI) broth, a standard microbiological culture medium, rather than as a subject of therapeutic investigation. No randomized controlled trials, observational cohort studies, or even open-label pilot studies with human subjects have been identified in PubMed or Cochrane databases. The current evidence base is insufficient to substantiate any efficacy claim, and the ingredient does not meet the evidentiary threshold required by regulatory bodies such as the FDA or EFSA for a qualified health claim.

Nutritional Profile

Bovine heart tissue extract is protein-dense, with crude protein comprising approximately 60–75% of dry weight, derived from myofibrillar proteins (myosin ~25–30% of total protein, actin ~15–20%), contractile regulatory proteins (tropomyosin, troponin complex), and sarcoplasmic proteins including metabolic enzymes (lactate dehydrogenase, creatine kinase, malate dehydrogenase). Collagen and connective tissue proteins contribute approximately 3–8% of total protein. Free amino acid profile is rich in glutamic acid, aspartic acid, leucine, lysine, and alanine. Creatine content is notably high at approximately 3–5 mg/g dry weight, alongside carnosine (~2–4 mg/g) and anserine (~1–2 mg/g) as endogenous dipeptides. Lipid content ranges from 5–15% dry weight depending on processing, comprising primarily phospholipids (phosphatidylcholine, phosphatidylethanolamine) and cholesterol (~200–400 mg/100g dry weight). Coenzyme Q10 (ubiquinone) is present at approximately 50–100 µg/g dry weight, reflecting the heart's high mitochondrial density. Iron content is elevated (~10–15 mg/100g dry weight) predominantly as heme iron with high bioavailability (~20–30% absorption rate). Zinc (~4–6 mg/100g), selenium (~20–40 µg/100g), and B vitamins including riboflavin (B2, ~1–2 mg/100g), niacin (B3, ~8–12 mg/100g), and cobalamin (B12, ~10–20 µg/100g) are present in measurable concentrations consistent with cardiac muscle tissue. As a laboratory extract prepared for culture media, concentrations vary significantly by manufacturer processing method, peptic or enzymatic digestion state, and lyophilization; precise nutritional delivery to humans is not established.

Preparation & Dosage

No clinically studied dosage ranges are available as no human clinical studies exist. Commercial products specify only technical specifications for laboratory use (2% solubility in water). Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

CoQ10, taurine, L-carnitine, vitamin B12, iron

Safety & Interactions

The safety profile of bovine heart tissue extract as an oral supplement has not been formally evaluated in human toxicology studies, and no established tolerable upper intake level or therapeutic dosage range exists. Individuals with cardiovascular disease, those taking anticoagulants such as warfarin, or patients on beta-blockers should exercise caution given uncharacterized peptide content that could theoretically influence cardiac signaling. Prion disease risk, while considered low with regulated sourcing, is a theoretical concern with any bovine tissue-derived product, and sourcing from BSE-controlled herds is advisable. Pregnant or breastfeeding individuals should avoid use due to a complete absence of safety data in these populations.